This decrease in macrophage activity, as well as increases in CD86 (an antigen-presenting cell-specific marker) and CD69 (a marker of early activation), align with findings in mouse models [24,25], which suggest that liver-residing macrophages are inducing the apoptosis of tumor-specific CD8 cells. The gene discussed is CD8A; the disease is neoplasm.